Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ahern

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Internal Medicine Journal|January 26, 2005
Isolated pulmonary hypertension in sclerodermaS R Cox, J G Walker, M Coleman, et al.
Annals of the Rheumatic Diseases|November 14, 2002
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysisT N Crotti, M D Smith, H Weedon, et al.
Rheumatology (Oxford, England)|April 20, 2001
Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsiesM D Smith, M C Kraan, J Slavotinek, et al.
Arthritis Research|February 15, 2001
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)M C Kraan, D D Patel, J J Haringman, et al.
Arthritis and Rheumatism|August 1, 1997
Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritisP P Youssef, D R Haynes, S Triantafillou, et al.
Asian Pacific Journal of Allergy and Immunology|November 30, 2004
Genomic instability in sclerodermaP J Roberts-Thomson, D A Male, J G Walker, et al.
Internal Medicine Journal|July 18, 2001
Scleroderma in South Australia: epidemiological observations of possible pathogenic significanceP J Roberts-Thomson, M Jones, P Hakendorf, et al.
Biomaterials|November 11, 2003
Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerinT N Crotti, M D Smith, D M Findlay, et al.
Annals of the Rheumatic Diseases|June 1, 1990
Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled studyC S Wong, G Champion, M D Smith, et al.
Internal Medicine Journal|June 16, 2010
Survival in scleroderma: results from the population-based South Australian RegisterP Hissaria, S Lester, P Hakendorf, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Internal Medicine Journal|January 26, 2005
Isolated pulmonary hypertension in sclerodermaS R Cox, J G Walker, M Coleman, et al.
Annals of the Rheumatic Diseases|November 14, 2002
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysisT N Crotti, M D Smith, H Weedon, et al.
Rheumatology (Oxford, England)|April 20, 2001
Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsiesM D Smith, M C Kraan, J Slavotinek, et al.
Arthritis Research|February 15, 2001
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)M C Kraan, D D Patel, J J Haringman, et al.
Arthritis and Rheumatism|August 1, 1997
Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritisP P Youssef, D R Haynes, S Triantafillou, et al.
Asian Pacific Journal of Allergy and Immunology|November 30, 2004
Genomic instability in sclerodermaP J Roberts-Thomson, D A Male, J G Walker, et al.
Internal Medicine Journal|July 18, 2001
Scleroderma in South Australia: epidemiological observations of possible pathogenic significanceP J Roberts-Thomson, M Jones, P Hakendorf, et al.
Biomaterials|November 11, 2003
Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerinT N Crotti, M D Smith, D M Findlay, et al.
Annals of the Rheumatic Diseases|June 1, 1990
Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled studyC S Wong, G Champion, M D Smith, et al.
Internal Medicine Journal|June 16, 2010
Survival in scleroderma: results from the population-based South Australian RegisterP Hissaria, S Lester, P Hakendorf, et al.
Pageof 13